BOIRON SA (BOI.PA) Stock Fundamental Analysis
Europe - EPA:BOI - FR0000061129 - Common Stock
27.7 EUR
+0.05 (+0.18%)
Overall BOI gets a fundamental rating of 4 out of 10. We evaluated BOI against 53 industry peers in the Pharmaceuticals industry. While BOI has a great health rating, there are worries on its profitability. BOI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year BOI was profitable.
BOI had a positive operating cash flow in the past year.
Each year in the past 5 years BOI has been profitable.
BOI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.45%, BOI is doing worse than 60.38% of the companies in the same industry.
The Return On Equity of BOI (5.25%) is comparable to the rest of the industry.
The Return On Invested Capital of BOI (4.43%) is worse than 60.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BOI is significantly below the industry average of 15.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.45% | ||
| ROE | 5.25% | ||
| ROIC | 4.43% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
1.3 Margins
BOI has a Profit Margin (3.84%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BOI has declined.
With a Operating Margin value of 5.26%, BOI is not doing good in the industry: 60.38% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of BOI has declined.
BOI's Gross Margin of 73.71% is fine compared to the rest of the industry. BOI outperforms 62.26% of its industry peers.
In the last couple of years the Gross Margin of BOI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | 3.84% | ||
| GM | 73.71% |
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
BOI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BOI remains at a similar level compared to 1 year ago.
The number of shares outstanding for BOI has been reduced compared to 5 years ago.
The debt/assets ratio for BOI is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.64 indicates that BOI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.64, BOI is in line with its industry, outperforming 49.06% of the companies in the same industry.
BOI has a debt to FCF ratio of 0.49. This is a very positive value and a sign of high solvency as it would only need 0.49 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.49, BOI belongs to the best of the industry, outperforming 94.34% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that BOI is not too dependend on debt financing.
BOI's Debt to Equity ratio of 0.04 is amongst the best of the industry. BOI outperforms 86.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.49 | ||
| Altman-Z | 3.64 |
ROIC/WACC0.55
WACC8.08%
2.3 Liquidity
BOI has a Current Ratio of 2.39. This indicates that BOI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BOI (2.39) is better than 79.25% of its industry peers.
BOI has a Quick Ratio of 1.46. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.46, BOI is doing good in the industry, outperforming 79.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.39 | ||
| Quick Ratio | 1.46 |
3. Growth
3.1 Past
The earnings per share for BOI have decreased strongly by -18.25% in the last year.
Measured over the past years, BOI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.40% on average per year.
BOI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.80%.
BOI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.63% yearly.
EPS 1Y (TTM)-18.25%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
3.2 Future
BOI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.73% yearly.
Based on estimates for the next years, BOI will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 24.73, the valuation of BOI can be described as rather expensive.
BOI's Price/Earnings ratio is in line with the industry average.
BOI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.69.
Based on the Price/Forward Earnings ratio of 11.98, the valuation of BOI can be described as reasonable.
71.70% of the companies in the same industry are more expensive than BOI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, BOI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.73 | ||
| Fwd PE | 11.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BOI is valued cheaper than 90.57% of the companies in the same industry.
79.25% of the companies in the same industry are more expensive than BOI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.04 | ||
| EV/EBITDA | 5.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BOI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.47
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BOI has a Yearly Dividend Yield of 4.33%, which is a nice return.
BOI's Dividend Yield is rather good when compared to the industry average which is at 3.00. BOI pays more dividend than 83.02% of the companies in the same industry.
BOI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.33% |
5.2 History
The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
BOI pays out 107.57% of its income as dividend. This is not a sustainable payout ratio.
DP107.57%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPA:BOI (10/21/2025, 5:29:53 PM)
27.7
+0.05 (+0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners6.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap486.13M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.33% |
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP107.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.73 | ||
| Fwd PE | 11.98 | ||
| P/S | 0.96 | ||
| P/FCF | 13.04 | ||
| P/OCF | 9.19 | ||
| P/B | 1.32 | ||
| P/tB | 1.95 | ||
| EV/EBITDA | 5.99 |
EPS(TTM)1.12
EY4.04%
EPS(NY)2.31
Fwd EY8.35%
FCF(TTM)2.12
FCFY7.67%
OCF(TTM)3.02
OCFY10.89%
SpS28.77
BVpS21.03
TBVpS14.24
PEG (NY)4.47
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.45% | ||
| ROE | 5.25% | ||
| ROCE | 5.9% | ||
| ROIC | 4.43% | ||
| ROICexc | 5.25% | ||
| ROICexgc | 7.65% | ||
| OM | 5.26% | ||
| PM (TTM) | 3.84% | ||
| GM | 73.71% | ||
| FCFM | 7.39% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexcg growth 3Y-33.41%
ROICexcg growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.9
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.49 | ||
| Debt/EBITDA | 0.2 | ||
| Cap/Depr | 35.13% | ||
| Cap/Sales | 3.1% | ||
| Interest Coverage | 30.02 | ||
| Cash Conversion | 74.49% | ||
| Profit Quality | 192.52% | ||
| Current Ratio | 2.39 | ||
| Quick Ratio | 1.46 | ||
| Altman-Z | 3.64 |
F-Score7
WACC8.08%
ROIC/WACC0.55
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.25%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-9.69%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y108.9%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y55.98%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%